MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$316,292
Unit: Dollar
Positive Cash Flow Breakdown
Accounts receivable, net
Stock based compensation
Accretion and amortization expen...
Others
Negative Cash Flow Breakdown
Net loss
Proceeds from (repayment to) sho...
Inventory
Preferred stock dividend
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Property, plant and equipment
0
-
-
0
Net cash used in investing activities
0
-
-
0
Loss (gain) on debt and share conversion and redemption
0
0
7,181
0
Issuance of shares for services
-
0
3,770
0
Effect of exchange rate changes on cash
-
-
-33,137
-26,883
Advance from customers
0
785,610
-1,150,000
1,895,920
Net loss
-959,468
-324,182
-717,067
-690,913
Issuance of warrants for services, at fair value
-
-
38,078
-
Issuance of warrants for brokers, at fair value
-
38,078
-
-
Stock based compensation
339,970
7,695
6,001
6,001
Property and equipment depreciation
-
1,488
1,488
1,489
Accretion and amortization expenses
-196,636
-204,713
-185,470
-202,141
Non cash lease expense
-
-
-
114,503
Right of use assets amortization
-
-
343,626
-
Change in fair value of derivative liabilities
-110,051
957
-134,335
-8,771
Accounts receivable, net
-572,932
1,363,078
-482,337
248,101
Operating right of use assets amortization
-
-465,839
-
-
Inventory
83,707
-633,463
-281,531
472,863
Deposits and other receivables
-122,675
260,646
299,435
-236,687
Accounts payable and accrued liabilities
80,348
172,776
167,767
-638,005
Operating right of use assets amortization
126,302
-
-
-
Property, plant and equipment depreciation
1,488
-
-
-
Net cash generated (used) in operating activities
507,227
-20,905
-740,291
415,630
Issuance of common shares, net
0
-
-
0
Redemption of preferred shares
-
0
0
200,000
Proceeds from (repayment to) convertible debentures, net
-
-
-77,003
0
Issuance of preferred shares, net
0
-
-
0
Conversion of preferred shares
0
-
-
-
Redemption of preferred shares
0
-
-
-
Conversion of convertible notes
0
-
-
-
Exercise of warrants for cash
0
-
-
-
Issuance of warrants to brokers
0
-
-
-
Issuance of warrants for private placement holders
0
-
-
-
Issuance of warrants for services
0
-
-
-
Federally guaranteed loans
0
-
-
-
Proceeds from (repayment to) convertible debentures, net
0
-
-
-
Issuance of shares from uplisting
0
-
-
-
Due to shareholders
0
-
-
-
Term loan, net
0
0
0
600,000
Proceeds from (repayment to) short term loan and promissory notes, net
-184,935
-162,549
804,328
298,367
Preferred stock dividend
6,000
6,000
6,000
12,033
Net cash provided (used) in financing activities
-190,935
-91,546
721,325
-507,748
Net increase (decrease) in cash during the period
316,292
-112,451
-18,966
-92,118
Cash, beginning of period
149,789
308,460
308,460
365,145
Cash, end of period
466,503
149,789
256,357
308,460
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts receivable, net
-$572,932
(-378.91%↓ Y/Y)
Stock based
compensation
$339,970
(5628.22%↑ Y/Y)
Accretion and
amortization expenses
-$196,636
(-28.04%↓ Y/Y)
Operating right of use
assets amortization
$126,302
Deposits and other
receivables
-$122,675
(-349.76%↓ Y/Y)
Change in fair value of
derivative liabilities
-$110,051
(-336.71%↓ Y/Y)
Accounts payable and
accrued liabilities
$80,348
(-83.69%↓ Y/Y)
Property, plant and
equipment depreciation
$1,488
Net cash generated
(used) in operating...
$507,227
(235.84%↑ Y/Y)
Canceled cashflow
$1,043,175
Net increase
(decrease) in cash during...
$316,292
(407.56%↑ Y/Y)
Canceled cashflow
$190,935
Net loss
-$959,468
(-42.78%↓ Y/Y)
Inventory
$83,707
(-63.29%↓ Y/Y)
Net cash provided
(used) in financing...
-$190,935
(-143.82%↓ Y/Y)
Proceeds from (repayment
to) short term loan...
-$184,935
(-141.88%↓ Y/Y)
Preferred stock dividend
$6,000
(1.39%↑ Y/Y)
Buy us a coffee
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)